前线白金继续在晚期膀癌中发挥作用
Ursula M Vogl1, Irene Testi2, Maria De Santis3
1Oncology Institute of Southern Switzerland EOC, Bellinzona, Switzerland.
European urology focus
|April 6, 2024
概括
西斯普拉丁加尼沃卢马布是一种有效的治疗尿路细胞癌. 这种组合优于像恩福图马布-维多丁和潘布罗利祖马布这样的新疗法,因为它具有既定的副作用概况和更少的治疗周期.
科学领域:
- 在瘤学瘤学.
- 尿癌研究 尿癌研究
背景情况:
- 西斯是一种用于肌肉侵入性或转移性尿路细胞癌的标准化疗法.
- 新兴的组合疗法正在研究晚期泌尿腺癌.
研究的目的:
- 评估基斯普拉丁化疗的疗效和优势,特别是与尼沃卢马布结合使用时,用于尿路细胞癌.
- 为了比较西斯普拉丁加尼沃卢马布与较新的治疗方案.
主要方法:
- 审查现有的临床数据和治疗指南.
- 对治疗疗效,副作用概况和治疗周期限制的比较分析.
主要成果:
- 西斯普拉丁仍然是尿路细胞癌的可行和有效的治疗选择.
- 将尼沃卢马布添加到西斯普拉丁药物中可以提高治疗效率.
- 基于西斯的疗法具有良好的副作用特征和有限的治疗周期,提供实用优势.
结论:
- 西斯普拉丁,特别是与尼沃卢马布结合使用,是治疗尿路细胞癌的高效疗法.
- 与较新的药物组合相比,基于西斯普拉丁的疗法已建立的安全性和可管理的治疗持续时间具有显著的好处.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K